We use third-party cookies to provide support. By continuing to browse this website, you accept our privacy policy.
Stockal+Disclaimer.pdf
1 own
2 watching
Current Price
$43.87
$-0.5
(-1.13%)
1 Week Returns
3 Months Returns
1 Year Returns

Get Started with as little as $1.00

Market Capitalization
1,554.08M
52-Week High
98.12
52-Week Low
34.7
Average Volume
0.26M
Dividend Yield
--
P/E Ratio
--
Market Capitalization1,554.08M
52-Week High98.12
52-Week Low34.7
Average Volume0.26M
Dividend Yield--
P/E Ratio--
What does the Stockal+Disclaimer.pdf do?
Nevro Corp., a medical device company, focuses on providing products for the patients suffering from chronic pain in the United States and internationally. It develops and commercializes the Senza spinal cord stimulation (SCS) system, an evidence-based neuromodulation platform for the treatment of chronic pain. The company sells its products through its direct sales force, and a network of sales agents and independent distributors. Nevro Corp. was founded in 2006 and is headquartered in Redwood City, California.
Read More
How much money does Stockal+Disclaimer.pdf make?
News & Events about Stockal+Disclaimer.pdf.
Ticker Report
1month ago
Shares of Nevro Corp. (NYSE:NVRO Get Rating) have been assigned an average rating of Hold from the thirteen ratings firms that are currently covering the stock, MarketBeat reports. Three analysts have rated the stock with a sell recommendation, five have assigned a hold ...
PR Newswire
1month ago
Nevro Comments on UnitedHealthcare Medical Coverage Policy Update Nevro Comments on UnitedHealthcare Medical Coverage Policy Update PR Newswire REDWOOD CITY, Calif., Oct. 10, 2022 REDWOOD CITY, Calif., Oct. 10, 2022 /PRNewswire/ --Nevro Corp.(NYSE: NVRO), a global medical device company that is...
Ticker Report
4 months ago
Shares of Nevro Corp. (NYSE:NVRO Get Rating) have earned an average recommendation of Hold from the fifteen brokerages that are currently covering the stock, Marketbeat Ratings reports. Two investment analysts have rated the stock with a sell recommendation, six have assigned a...
Zolmax
4 months ago
Virginia Retirement Systems ET AL grew its position in shares of Nevro Corp. (NYSE:NVRO Get Rating) by 27.9% in the 1st quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor owned 8,700 shares of the medical ...
Zolmax
5 months ago
Woodline Partners LP reduced its stake in shares of Nevro Corp. (NYSE:NVRO Get Rating) by 39.6% in the fourth quarter, according to its most recent disclosure with the Securities and Exchange Commission. The firm owned 99,005 shares of the medical equipment providers stock after selling 64,837 ...
Frequently Asked Questions
Frequently Asked Questions
What is Stockal+Disclaimer.pdf share price today?
plus_minus_icon
Can Indians buy Stockal+Disclaimer.pdf shares?
plus_minus_icon
How can I buy Stockal+Disclaimer.pdf shares from India?
plus_minus_icon
Can Fractional shares of Stockal+Disclaimer.pdf be purchased?
plus_minus_icon
What are the documents required to start investing in Stockal+Disclaimer.pdf stocks?
plus_minus_icon
What is today’s traded volume of Stockal+Disclaimer.pdf?
plus_minus_icon
What is today’s market capitalisation of Stockal+Disclaimer.pdf?
plus_minus_icon
What is the 52-Week High and Low Range of Stockal+Disclaimer.pdf?
plus_minus_icon
What percentage is Stockal+Disclaimer.pdf down from its 52-Week High?
plus_minus_icon
What percentage is Stockal+Disclaimer.pdf up from its 52-Week Low?
plus_minus_icon
Current Price
$43.87
$-0.5
(-1.13%)
1 Week Returns
3 Months Returns
1 Year Returns

Get Started with as little as $1.00

Get Started with as little as $1.00